In-depth analysis revealed a strong association between MGAT4EP expression levels and clinical staging in breast cancer, particularly among patients with lymph node metastasis and distant metastasis, where MGAT4EP expression was significantly up-regulated. The gene discussed is MGAT4EP; the disease is breast carcinoma.